Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Allergic rhinitis (AR) is a growing public health, medical and economic problem worldwide.
The current review describes the major discoveries related to AR during the past 2 years …

Abstract Purpose of Review Olfactory dysfunction in upper airway viral infections (common
cold, acute rhinosinusitis) is common (> 60%). During the COVID-19 outbreak, frequency of …

In this review, we discuss recent publications on asthma and review the studies that have
reported on the different aspects of the prevalence, risk factors and prevention, mechanisms …

Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …

Background It is unclear whether asthma and its allergic phenotype are risk factors for
hospitalization or severe disease from SARS‐CoV‐2. Methods All patients over 28 days old …

Abstract The coronavirus disease 2019 (COVID-19) pandemic causes an overwhelming
number of hospitalization and deaths with a significant socioeconomic impact. The vast …